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Postpneumonectomy empyema (PPE) is a rare 
but severe complication with an incidence rate of 4,4% 
to 16% (9,36,49). Seventy-five percent of PPE  occur 
within the first three months of pneumonectomy 
(38), however, it  may appear even years after the 
procedure (46). In up to 80% of the patients, PPE is 
associated with bronchopleural fistula (BPF) (49).  
Despite usage of various therapeutic approaches and 
techniques during the last five decades, successful 
therapy remains difficult and is often associated with 
high mortality rate (total of 10-20% and with BPF up 
to 50%), morbidity rate and prolonged hospitalization 
(1,26,38).
PPE development is adversely affected by dif-
ferent factors, especially benign disease and low-
er diffusing capacity for carbon monoxide (DLCO) 
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(p=0,001) followed by lower forced expiratory volume 
(FEV1), lower preoperative serum hemoglobin, right 
pneumonectomy, bronchial stump reinforcement, 
completion pneumonectomy,  timing of chest tube 
removal and amount of blood transfusions (9). Other 
major risk factors for PPE are immunosuppression, 
neoadjuvant or adjuvant therapy (12,39).
The incidence rate of PPE and BPF vary from 15 
to 1,3%. Recently, according to a large patients’ cohort 
study, it is of 3,8% (37). A shorter length and cover-
age of the bronchial stump as well as early extubation 
may prevent the risks of BPF. Bronchial stump clo-
sure with staples has a protective effect against BPF 
compared with suture closure (9,14). 
PPE affects a large size of the infected non-
collapsible chest cavity that is filled with pus and 
covered by poorly vascularized infected tissue. 
There are diverse sources of infection of the 
postpneumonectomy cavity. An incidental infection 
of the pleural cavity may ensue during the operation 
as result of spilling of secretions from the respiratory 
tree or after operation because of a leaking bronchial 
stump into the postpneumonectomy cavity (23). 
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An increase of mixed infections with two or three 
bacterial strains and an increase of Gram (–) bacteria 
including Pseudomonas aeruginosa has been ob-
served (22). A similar observation has been published 
(29), however, cultures are often negative because of 
the antibiotic treatment. Analysis of bacterial culture 
allow to make an appropriate decision of changing 
the antibiotic preliminarily used in perioperative 
prophylaxis.
Surgical principles of treatment for infected 
spaces are well-known and include evacuation of 
pus and debridement of the infected tissue combined 
with obliteration, marsupialization, or opening of the 
infected cavity (36).
Emergency tube thoracostomy drainage should 
be the first step in the acute phase of the empyema. 
Patients should be instructed to lie with their 
operative side until the empyema  could be drained 
to prevent spillage into the remaining lung.  Bron-
choscopy is then performed to confirm or rule out 
BPF. Most cases of operative mortality are secondary 
to respiratory failure from pulmonary infection that 
may have occurred from spillage of the empyema 
across the BPF into the contralateral lung (49). 
Sterilization (debridement and closure of pres-
ent BPF) and obliteration of pleural cavity (antibiotic 
plombage, muscle and omental pedicle flaps or tho-
racoplasty) follow the first step. 
There is no universally appropriate treatment 
and that is why management depends upon the PPE 
stage, BPF presence and patient’s general condi-
tion (36). In the absence of BPF, aggressive surgery 
is questioned because of its high morbidity rate and 
because it does not totally prevent recurrences (9).
Pleural cavity drainage alone is considered a 
palliative procedure (49). As a definitive treatment 
it includes irrigation by additional apical drain and 
endoscopic closure of small bronchial fistulas by 
fibrine glue if needed. The shortcomings of the meth-
od are prolonged treatment, discomfort caused by 
the intrapleural drain, uncertain cavity obliteration 
and chest deformity. Nevertheless, eight patients 
with PPE are successfully treated by continuous soft 
tube thoracostomy, intrapleural fibrinolysis, and 
antibiotics (6).
In 1963, a two-stage ‘Clagett’ procedure has been 
introduced (7). It consists of i) open pleural drainage 
(open window thoracostomy, OWT) with pleural 
space cleansing and, eventually, obliteration by daily 
dressing changes through the thoracostomy for 4-6 
weeks followed by ii) obliteration of the pleural cavity 
with debridement antibiotic solutions (DABs) at the 
time of chest wall closure. The procedure has been 
successful in 88% of the cases (n=14). However, it has 
resulted in prolonged hospitalization and significant 
morbidity rate. Usually, failure is due to persistent or 
recurrent BPF (41). In order to address these failures, 
‘Clagett’ procedure is modified with initial bron-
chial stump reinforcement and reduction of pleu-
ral cavity size by transposition of well-vascularized 
extrathoracic muscle as an intermediate step before 
obliteration of the pleural cavity with antibiotic 
solution (29). The success of this modification (n-
28) is 83,9%. However, surgical reinterventions are 
numerous and hospitalization time is too long (29).  
Mayo Clinic experience of 84 patients shows 
that initial chest closure before hospital discharge 
fails in 19% while after a second ‘Clagett’ procedure, 
chest walls are successfully closed in 88% of the 
patients (50). Eight patients (9,5% of the cases) should 
live with a permanent thoracic wall defect. BPF 
healing is achieved in all the 55 patients. However, 
the recurrence rate after the first attempt is 18%, and 
that after the second attempt 5% only. Perioperative 
mortality rates is 7,1%. Late PPE onset and immediate 
thoracostomy creation (24) as well as age under 65 years 
(50) are significant predictors of OWT closure.  As 
the process of pleural space obliteration after OWT 
alone may take up to two years (48), the need for 
further surgery to obliterate the pleural space are 
suggested (35,50). Different extrathoracic muscles 
or omental transposition can be applied to obliterate 
the pleural space. Both omentum and muscle flaps 
may play an important role in infection control. 
Furthermore, they stimulate neoangiogenesis of 
ischemic bronchial stumps. Using intrathoracic 
muscular or omental transposition one should kept 
in mind that no residual space should be left and that 
a sufficient number of flaps must be available to fill 
any space. Extrathoracic muscle flap advantages are 
reliable blood supply, ability to reach almost any part 
of the pleural space, and sufficient volume to fill the 
cavity (25,29). Their application may, however, lead to 
functional impairment and thus they are contraindi-
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cated in debilitated patients, following radiotherapy 
and posterolateral thoracotomy. 
Cavity obliteration should be carried out at least 
three months after an operation for benign disease 
(24). The arguments against operative OWT closure 
within two years of PPE in lung cancer patients are 
the acceptable probability of spontaneous resolution 
and the risk of recurrent disease  (34). In this setting, 
waiting no less than six months between performing 
and closing OWT is recommended (13). 
Omental pedical flap maintains a rich blood 
supply and lymph circulation, accelerates vascular-
ization due to angiogenic factors, promotes drug 
transfer in the peripheral blood to affected areas, ex-
erts potent anti-inflammatory and self-cleaning ef-
fects and has a sufficient volume. The procedure is 
minimally invasive and simple (37). Omentoplasty 
could be applied in poor-risk patients, in patients 
with history of radiotherapy and posterolateral 
thoracotomy, and, especially, in patients with BPF 
(27).
BPF closure is of paramount importance in PPE 
treatment. Different techniques depend on the type 
and size of the insufficiency. Endoscopic treatment of 
BPF less than 3 mm with various glues and sclerosing 
agents is a minimally invasive procedure that plays 
an essential role, particularly in high risk patients 
(21,28,44,45).
The stump can be accessed via the same 
pleural cavity through the contralateral pleural 
cavity in case of left stump fistula (31) and by 
means of transmediastinal video-assisted thora-
coscopy (VATS) application (4). The advantages of 
transsternal transpericardial closure of BPF or Abru-
zzini technique (2) are the following: avoidance of 
areas of infection, scarring in previous surgical 
fields, devascularized bronchus, and cosmetic and 
functional deformities of the thorax because of 
thoracoplasty. This technique is an alternative in the 
management of persistent fistula after repair by other 
techniques (43). The disadvantage of this method is 
that the residual empyema space is not dealt with at the 
same time with BPF closure and additional surgical 
procedures are needed. Several authors performed 
carinal resection using the transsternal approach in 
cases with a short, less than 5 mm bronchial stump 
(8,23,31,33,42). A miniinvasive Abruzzini-like tech-
nique using three simultaneous approaches such as 
cervical videomediastinoscopy, right anterior medi-
astinotomy and parasternal thoracoscopic port has 
been developed (40).
Prolonged and very expensive treatment 
represents the disadvantages of the older procedures 
for PPE treatment.  
In patients with early PPE associated with BPF, 
a 100% success rate with shorter hospitalization and 
decreased morbidity are reported (41). Their ‘Clagett’ 
procedure modification is based on emergency tube 
drainage followed by thoracotomy, debridement, 
bronchial stump resuture, and immediate chest cav-
ity closure. Postoperative pleural irrigation and space 
obliteration by antibiotic solution constitute the 
final part of the treatment. This approach should, 
however, be considered only in a highly selected 
subset of patients. 
Accelerated Weder method may be considered 
an advancement of ‘Clagett’ procedure. It leads to a 
high success rate of 97,3% with a mean postoperative 
hospital stay of 17-18 days (36,37). The therapy 
consists of repeated open surgical debridement of the 
pleural cavity after achievement of general anesthesia, 
a negative pressure wound therapy (11) of the 
temporarily closed chest cavity filled with povidone-
iodine-soaked towels, and continuous suction and 
systemic antimicrobial therapy. If present, BPF are 
closed and reinforced either with a muscle flap, or 
with the omentum. Finally, the pleural space is filled 
with an antibiotic solution and definitively closed.
The procedure is repeated every 48 hours and, 
usually, a mean amount of 3,5 procedures is enough 
until the chest cavity is macroscopically clean.
A video-assisted modification of Weder 
procedure is recently introduced in three patients 
(32). The previous thoracotomy is not open. In cases 
with a previous chest tube drainge, a wide excision of 
the surrounding soft tissues such as skin and muscles 
is carried out and the prepared 4-cm thoracotomy is 
applied for inserting the telescope and the working 
instruments into the cavity. In cases without such 
a drainage, a small 4 cm muscle-sparing axillar 
thoracotomy is performed. A radical pleural cavity 
VATS debridement (VATSD) is carried out followed 
by irrigation with diluted povidone-iodine solution 
(1:10). At the end of every surgical intervention, but 
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before the definitive closure, the pleural cavity is 
packed with dressings soaked with povidone-iodine 
solution, carefully avoiding the mediastinal shift 
through overstuffing the thoracic cavity. No intra-
thoracic drain (less pain and mobile patient) is put 
and pleural cavity is carefully closed with interrupt-
ing suturing of the soft tissues (32). Every 48 hours, 
the antiseptic packings are changed and the surgical 
debridement is repeated in the operating theatre until 
the chest cavity is macroscopically clean. Finally, 
the pleural space is obliterated with an antibiotic 
solution and the minithoracotomy is definitively 
closed watertight. General endotracheal anesthesia is 
given for the first surgical session of the procedures 
based on the assumption that more extensive surgery 
might be required. The anesthesia for the remaining 
sessions and for postoperative pain relief is high tho-
racic epidural anesthesia via catheter with preserved 
self-ventilation. PPE is successfully treated in all the 
patients during three sessions needed with a mean 
hospital stay of 10,3 days followed by excellent long-
term functional and cosmetic results. 
Limited experience with VATSD in PPE man-
agement may be due to the fear of using VATS for 
a severe and potentially lethal complication as well 
as of overlooking the infected tissues in the regions 
that are difficult to reach with the thoracoscope (19). 
However, there is no evidence that success relies on 
complete debridement of all the infected tissues. If 
VATS  does not accomplish as thorough a pleural 
cleaning as does thoracotomy, it is often successful 
because the bacterial load and inflammatory 
exudates are reduced below a critical level allowing 
the pleural space to recover (47). 
In 9 patients, infected materials are cleaned 
by videothoracoscopy and subsequent postop-
erative antibiotic irrigation according to culture 
sensitivity via single chest tube drainage twice a 
day (18). Empyema is considered eradicated, if three 
consecutivve cultures show no bacterial growth 
with a mean hospital stay of 29 days. VATSD is ap-
plied, too (15), however, without any postoperative 
irrigation. In the case of persistent infectious 
symptoms (27% recurrence rate), thoracoscopy is 
not repeated and OWT is performed. Treatment be-
gins with pleural cavity antibiotic irrigation for 10 
days through two chest tubes twice a day (5). Pleu-
ral instillation of 250000 U streptokinase is done 
two hours prior to procedure.  Then VATSD is car-
ried out under general anaesthesia and tube drainage 
is placed in the chest cavity. This protocol provides 
satisfactory results in terms of hospital stay and 
number of sepsis recurrences. Three PPE patients 
are treated with repeated VATSD and intermittent 
lavage with polyvinyl pyrolidine-iodine solution 
and streptocinase/streptodornase (10). Three to 
seven thoracoscopies under general anaesthesia are 
required to sterilize the pleural cavity. After a median 
follow-up of 14 months all these patients feel well and 
present without any evidence of infection. 
A repeated VATSD and lavage with povidone-
iodine solution are successfully carried out every 48 
hours in four patients via 2 ports, too, however, only 
the first VATSD is done under general anaesthesia 
(32). The next VATS procedures are performed using 
epidural analgesia at the T6-8 interspace. Between 
the procedures the pleural cavity is filled with povi-
done-iodine solution (1:10), without any intrapleural 
tube drainage. The advantages of this VATSD pro-
tocol (32) are the following: restoration of aseptic 
PPE cavity in 100% of the patients, no chest tube 
drainage-less pain, mobile patient, only the first ses-
sion is under general anaesthesia, good quality of 
life and functional results,  short hospital stay and 
moderate costs,  low morbidity rate and possibility 
to perform further aggressive treatment in case of 
failure. The relative  disadvantages are the follow-
ing: three VATSD within five days and inadequate 
reimburcement by the health insurance funds as one 
procedure for hospitalization is paid only.
Several authors emphasize that limited 
thoracoplasty is an excellent therapeutic option for 
treating PPE, avoiding multiple operative procedures 
and the psychological drawbacks of prolonged 
hospitalization or of definitive open drainage 
(16,17,20). About 75% of the patients start to work 
again (30). 
Thoracopleuroplasty as described by Andrews 
(3) allows a good control of infection with complete 
evacuation of the products of empyema under direct 
vision, an immediate closure of any bronchial fistula, 
an one stage-procedure, and a rapid and most often 
simple postoperative recovery (19). This surgical 
procedure could be at least an alternative method to 
open thoracostomy always when a secondary closure 
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seems uncertain, or is used in case of failure of other 
treatment modalities. These results and the quality 
of life after this thoracopleuroplasty should support 
the rediscovery of this time-honoured procedure in 
properly selected patients (19).
In conclusion, PPE treatment usual-
ly as a combination of several methods should be 
individually tailored for every patient. Accelerated 
Weder procedure is an effective method in PPE with 
or without BPF. Extrathoracic muscle myoplasty is 
an excellent method for obliteration of PPE cavity 
with BPF. Due to its detersion capacity and sufficient 
volume omentoplasty is effective and safe procedure 
in selected cases of PPE with BPF, too. VATSD and 
VATS modification of Weder procedure can manage 
most PPE patients with minor BPF successfully treat-
ed bronchoscopically or without any BPF. They do 
not preclude more aggressive surgical treatment in 
case of failure or relapse. 
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